We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Remitly
RELY
$5.5B
| $131K | ﹤0.01% |
6,999
+6,976
| +30,330% | +$145K |
|
1552
Qiagen
QGEN
$9.03B
| $130K | ﹤0.01% |
2,715
-1,024
| -27% | -$44.5K |
|
1553
Bank of Hawaii
BOH
$3.05B
| $130K | ﹤0.01% |
+1,927
| New | +$128K |
|
|
CVSA
1554
Covista Inc
CVSA
$4.79B
| $129K | ﹤0.01% |
1,016
-120
| -11% | -$14.2K |
|
1555
AMC Global Media
AMCX
$509M
| $127K | ﹤0.01% |
20,292
+11,493
| +131% | +$72.6K |
|
1556
Acadia Realty Trust
AKR
$2.87B
| $127K | ﹤0.01% |
6,850
-7,848
| -53% | -$152K |
|
1557
Descartes Systems
DSGX
$6.91B
| $127K | ﹤0.01% |
1,246
+254
| +26% | +$26.8K |
|
1558
City Holding Co
CHCO
$2.01B
| $127K | ﹤0.01% |
1,034
| – | – |
|
1559
Global Payments
GPN
$24.5B
| $126K | ﹤0.01% |
1,579
+83
| +6% | +$6.57K |
|
1560
Royalty Pharma
RPRX
$27.6B
| $126K | ﹤0.01% |
3,500
| – | – |
|
1561
Cohu
COHU
$2.45B
| $126K | ﹤0.01% |
6,548
+5,691
| +664% | +$96K |
|
|
EXAS
1562
DELISTED
Exact Sciences
EXAS
| $126K | ﹤0.01% |
+2,368
| New | +$120K |
|
1563
W.R. Berkley
WRB
$25.4B
| $126K | ﹤0.01% |
1,709
-31
| -2% | -$2.22K |
|
1564
DuPont de Nemours
DD
$18.7B
| $125K | ﹤0.01% |
1,451
-2,359
| -62% | -$196K |
|
1565
Raymond James Financial
RJF
$33.9B
| $122K | ﹤0.01% |
794
-20
| -2% | -$2.86K |
|
1566
Schrodinger
SDGR
$1.53B
| $121K | ﹤0.01% |
6,000
-4,000
| -40% | -$91.3K |
|
1567
Enterprise Financial Services Corp
EFSC
$2.3B
| $120K | ﹤0.01% |
2,182
+1,123
| +106% | +$58.6K |
|
1568
Vishay Intertechnology
VSH
$4.87B
| $116K | ﹤0.01% |
7,296
-200,208
| -96% | -$2.78M |
|
1569
Southern Missouri Bancorp
SMBC
$818M
| $113K | ﹤0.01% |
2,065
| – | – |
|
1570
Archer Daniels Midland
ADM
$38.1B
| $110K | ﹤0.01% |
2,091
-8,531
| -80% | -$415K |
|
|
BBT
1571
Beacon Financial Corp
BBT
$2.64B
| $110K | ﹤0.01% |
4,395
| – | – |
|
|
TWO
1572
DELISTED
Two Harbors Investment
TWO
| $109K | ﹤0.01% |
10,090
-355
| -3% | -$4K |
|
1573
DaVita
DVA
$11.4B
| $109K | ﹤0.01% |
762
-139
| -15% | -$19.7K |
|
1574
Northeast Bank
NBN
$1.11B
| $108K | ﹤0.01% |
1,216
-82
| -6% | -$7K |
|
1575
Hershey
HSY
$36.4B
| $107K | ﹤0.01% |
644
-5
| -0.8% | -$824 |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.